triamterene and hydrochlorothiazide

Generic: triamterene and hydrochlorothiazide

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name triamterene and hydrochlorothiazide
Generic Name triamterene and hydrochlorothiazide
Labeler pd-rx pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydrochlorothiazide 25 mg/1, triamterene 37.5 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 55289-090
Product ID 55289-090_41999499-b90e-0afa-e063-6294a90aea28
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA073449
Listing Expiration 2026-12-31
Marketing Start 1993-09-23

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc] potassium-sparing diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe] decreased renal k+ excretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55289090
Hyphenated Format 55289-090

Supplemental Identifiers

RxCUI
310812
UNII
0J48LPH2TH WS821Z52LQ
NUI
N0000175359 N0000175419 M0471776 N0000008859 N0000175418

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name triamterene and hydrochlorothiazide (source: ndc)
Generic Name triamterene and hydrochlorothiazide (source: ndc)
Application Number ANDA073449 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
  • 37.5 mg/1
source: ndc
Packaging
  • 15 TABLET in 1 BOTTLE, PLASTIC (55289-090-15)
  • 30 TABLET in 1 BOTTLE, PLASTIC (55289-090-30)
  • 90 TABLET in 1 BOTTLE, PLASTIC (55289-090-90)
source: ndc

Packages (3)

Ingredients (2)

hydrochlorothiazide (25 mg/1) triamterene (37.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "41999499-b90e-0afa-e063-6294a90aea28", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000008859", "N0000175418"], "unii": ["0J48LPH2TH", "WS821Z52LQ"], "rxcui": ["310812"], "spl_set_id": ["e505484d-b600-4d13-a4b9-278dc4a2e73a"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]", "Decreased Renal K+ Excretion [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Potassium-sparing Diuretic [EPC]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE, PLASTIC (55289-090-15)", "package_ndc": "55289-090-15", "marketing_start_date": "20170120"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (55289-090-30)", "package_ndc": "55289-090-30", "marketing_start_date": "20160211"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (55289-090-90)", "package_ndc": "55289-090-90", "marketing_start_date": "20160216"}], "brand_name": "Triamterene and Hydrochlorothiazide", "product_id": "55289-090_41999499-b90e-0afa-e063-6294a90aea28", "dosage_form": "TABLET", "pharm_class": ["Decreased Renal K+ Excretion [PE]", "Increased Diuresis [PE]", "Increased Diuresis [PE]", "Potassium-sparing Diuretic [EPC]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "55289-090", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triamterene and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "TRIAMTERENE", "strength": "37.5 mg/1"}], "application_number": "ANDA073449", "marketing_category": "ANDA", "marketing_start_date": "19930923", "listing_expiration_date": "20261231"}